Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.4.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.4.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.4.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.4.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.541ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.25ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.25ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.189EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.189EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.189ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.189ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.189EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.189EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.189ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.189ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.563EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.563EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.563ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.563ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.563EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.563EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.563ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.563ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.34EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.36.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.34ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.36.34ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.36.34EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used